(firstQuint)The Safety, Tolerability and Pharmacokinetic Study of Yimitasvir in Healthy Adults Subjects.

 This was a Randomized,Double-blind, Placebo-controlled, Single Ascending Dose, Single-center Study to Assess the Safety, Tolerability and Pharmacokinetic of Yimitasvir in Healthy Adults Subjects A total of 56 healthy subjects were divided into 7 groups, with each group consisting of 8 subjects.

 Six of the subjects received the investigational drug, and two received placebo.

 All of the subjects received a single dose.

.

 The Safety, Tolerability and Pharmacokinetic Study of Yimitasvir in Healthy Adults Subjects@highlight

The Safety, Tolerability and Pharmacokinetic Study of Chronic Hepatitis C Treatment Drug Yimitasvir in Healthy Adults Subjects.

